We are live on
!
Find out more
iShares Biotechnology ETF
414 hedge funds and large institutions have $6.44B invested in iShares Biotechnology ETF in 2015 Q3 according to their latest regulatory filings, with 56 funds opening new positions, 145 increasing their positions, 140 reducing their positions, and 57 closing their positions.
New
Increased
Maintained
Reduced
Closed
4% more repeat investments, than reductions
Existing positions increased: 145 | Existing positions reduced: 140
2% less first-time investments, than exits
New positions opened: 56 | Existing positions closed: 57
2% less capital invested
Capital invested by funds: $6.6B → $6.44B (-$165M)
1% less funds holding
Funds holding: 419 → 414 (-5)
31% less funds holding in top 10
Funds holding in top 10: 42 → 29 (-13)
41% less call options, than puts
Call options by funds: $866M | Put options by funds: $1.47B
Holders
414
Holders Change
-5
Holders Change %
-1.19%
% of All Funds
11.56%
Holding in Top 10
29
Holding in Top 10 Change
-13
Holding in Top 10 Change %
-30.95%
% of All Funds
0.81%
New
56
Increased
145
Reduced
140
Closed
57
Calls
$866M
Puts
$1.47B
Net Calls
-$602M
Net Calls Change
+$629M
Top Buyers
| 1 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$377M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$298M |
| 3 |
Morgan Stanley
New York
|
+$272M |
| 4 |
Goldman Sachs
New York
|
+$179M |
| 5 |
Citigroup
New York
|
+$88.5M |
